Evidence map›Paper›PMID 29356453›Full record

ArticleJournal of diabetes investigation2018

Association between 1p13 polymorphisms and peripheral arterial disease in a Chinese population with diabetes.

Jiangyuan Qin, Jinli Tian, Guanhua Liu, Yazhong Zhang, Luobing Tian, Yanfeng Zhen, Hewei Zhang, Jing Xu, Xueling Sun, Hui Fang

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Association between Genetic Variants ofJournal of cardiovascular development and disease · 2023
    Review
  4. Polymorphism of rs599839 in theJournal of cardiovascular and thoracic research · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jiangyuan QinDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
Jinli TianSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Guanhua LiuDepartment of Orthopedics, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Yazhong ZhangSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Luobing TianSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Yanfeng ZhenSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Hewei ZhangSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Jing XuSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Xueling SunSecond Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Hui FangDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.ORCID http://orcid.org/0000-0003-1926-1270
Second Hospital of Tangshan · CNHebei Medical University · CNTangshan Gongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionVariants on chromosome 1p13 have been associated with coronary artery disease and acute myocardial infarction risk in different ethnic groups. The present study aimed to investigate the association between 1p13 polymorphisms and the development of peripheral artery disease (PAD) in a Chinese population with type 2 diabetes mellitus. MATERIALS AND

methods1p13 polymorphisms, rs599839, rs646776 and rs12740374, were assessed in a cohort of 882 type 2 diabetes mellitus patients including 440 type 2 diabetes mellitus patients with PAD (DM + PAD group) and 442 patients without PAD (DM group). Genotyping was carried out using TaqMan assay.

resultsCompared with the DM group, the frequencies of the minor G allele of both rs599839 and rs646776 and the minor T allele of rs12740374 decreased (P = 0.013, P = 0.019 and P = 0.005, respectively), and the frequencies of rs599839 AG + GG, rs646776 AG + GG and rs12740374 CT+TT genotypes were statistically significantly decreased as well (P = 0.017, P = 0.011 and P = 0.007, respectively) in the dominant model in the DM + PAD group than in the DM group. Multivariate unconditional logistic regression analyses adjusted for age, glycated hemoglobin, triglyceride, low-density lipoprotein cholesterol, smoking, hypertension, diabetes duration, coronary heart disease and cerebral infarction showed that the genotypic distribution of rs599839 AG + GG, rs646776 AG + GG and rs12740374 CT + TT remained statistically different between the DM and DM + PAD group (P = 0.014, P = 0.003 and P = 0.004, respectively). The frequencies of haplotype GGT were statistically significantly different between groups (P = 0.08).

conclusionsThe present study strongly supports that genotypes of rs599839, rs646776 and rs12740374 on 1p13 are protective factors for diabetic PAD in a Chinese population. Haplotype GGT generated by rs599839, rs646776 and rs12740374 might also decrease the risk of the disease.

Indexed as

AgedAsian PeopleChromosomes, Human, Pair 1Diabetes Mellitus, Type 2FemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMiddle AgedPeripheral Arterial DiseasePolymorphism, Single Nucleotide1p13Diabetic peripheral arterial diseaseSingle-nucleotide polymorphism

Identifiers

PMID29356453
PMCPMC6123029
OpenAlexW2791092831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.